Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
31 Cards in this Set
- Front
- Back
Acyclovir (also known as aciclovir) |
Antiviral drug that is used to fight herpes virus infections |
|
Alginates |
Polymers derived from brown seaweeds, which are added to antacid mixtures to form a neutral layer on the top of the stomach acid |
|
Analgesics |
Pharmaceutical that relieves or prevents pain |
|
Antacid |
Base that neutralizes the excess acidity and relieves the pain associated with heatburn and peptic ulcers |
|
Anti-foaming agents |
Chemicals that reduce surface tensions of gas bubbles, coasing them to coalesce, e. g. dimethicone |
|
Anxiolytics |
Drugs used to treat anxiety disorders |
|
Chiral |
Molecule without a plane of symmetry |
|
Depressant |
Chemical agent that diminishes function or activity of a specific part of body, in particular central nervous system |
|
Effective dosage (ED50) |
Amount of pharmaceutical that would produce therapeutic response in 50% of population |
|
Gas-liquid chromatography (GLC) |
Type of chromatography that uses liquid stationary phase and gaseous mobile phase or carrier gas |
|
HIV (Human immunodeficiency virus) |
Virus that causes AIDS |
|
Intramuscular |
Into a muscle |
|
Intravenous |
Into a vein |
|
Lethal dosage (LD50) |
Amount of pharmaceutical that would kill (be lethal to) 50% of population |
|
Narcotic |
Analgesic that produces euphoria and causes loss of feeling of paralysis |
|
Pathogenic |
Disease-causing |
|
Placebo |
Pharmaceutically inert tablet (contains no medicine) |
|
Placebo effect |
Psychosomatic response to substance that should be ineffective |
|
Prophylactic |
Medication or treatment designed and disease to prevent disease from occuring |
|
Protease inhibitors |
Antiviriral drugs that act on enzyme responsible for cleaving polypeptydes made in the host cell by proviral DNA and so preventing the synthesis of structural proteins for new virions |
|
Retrovirus |
Protein-enveloped virus possessing RNA genome that replicates via DNA intermediate |
|
Reverse transcriptase inhibitors |
Anti-HIV drugs which interfere with process of transcription of proviral DNA by either inihibiting enzyme or competing with host cellular triphosphate nucleosides |
|
Side-effects |
Unwanted response to drug; not main effect of drug |
|
Stimulant |
Drug that stimulates central nervous system, making user feel less tired and more alert |
|
Subcutaneous |
Under skin |
|
Sympathomimetic drugs |
Drugs that mimic action of hormones such as epinephrine and neurotransmitters such as noradrenaline in the way in which they affect body |
|
Synergistic effect |
Enhancement of effect of one drug when taken in conjunction with another, e.g. ethanol (alcohol) |
|
Therapeutic window |
Ratio of lethal dose (LD50) to effective dose (ED50), i.e. LD50/ED50 |
|
Tolerance |
Body's ability to adsorb increasing amounts of drug over time without experiencing effect of drug |
|
Vasoconstrictor |
Drug that makes blood vessels narrower |
|
Virion |
Complete virus particle, consisting of nucleic acid surrounded by protective coat of protein |